|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| C12Q 1/68 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| G01N 33/50 | (2006.01) |
| (11) | Number of the document | 3892295 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21168360.2 |
| Date of filing the European patent application | 2012-05-23 | |
| (97) | Date of publication of the European application | 2021-10-13 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-26 |
| (46) | Date of publication of the claims translation | 2023-07-10 |
| (30) | Number | Date | Country code |
| PCT/EP2011/002576 | 2011-05-24 | WO | |
| PCT/EP2012/000006 | 2012-01-02 | WO |
| (72) |
SAHIN, Ugur , DE
KREITER, Sebastian , DE
DIKEN, Mustafa , DE
DIEKMANN, Jan , DE
KOSLOWSKI, Michael , GR
BRITTEN, Cedrik , DE
CASTLE, John , DE
LÖWER, Martin , DE
RENARD, Bernhard , DE
OMOKOKO, Tana , DE
DE GRAAF, Johannes Hendrikus , DE
|
| (73) |
BioNTech SE ,
An der Goldgrube 12, 55131 Mainz,
DE
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH , Freiligrathstrasse 12, 55131 Mainz, DE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Individualizuotos vakcinos nuo vėžio |
| INDIVIDUALIZED VACCINES FOR CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-04-23 | 14 | 289.00 EUR |
| 2026-05-23 |